59 related articles for article (PubMed ID: 9289540)
1. [Familial combined hyperlipidemia].
Rubiés-Prat J; Pedro-Botet J
Med Clin (Barc); 1997 Jun; 109(5):175-6. PubMed ID: 9289540
[No Abstract] [Full Text] [Related]
2. [Familial combined hyperlipidemia. I. Variation in the lipoprotein picture].
Vaverková H; Weinbergová O; Horcicka V; Kubasta M; Vrublovský P
Vnitr Lek; 1986 Sep; 32(9):878-86. PubMed ID: 3765425
[No Abstract] [Full Text] [Related]
3. Study of genetic variants of familial hyperlipidaemia in some xanthoma patients.
Gajra B; Talukder G; Panja SK
Indian J Dermatol; 1981 Jul; 26(3):1-3. PubMed ID: 7348242
[No Abstract] [Full Text] [Related]
4. Effect of combination nicotinic acid and gemfibrozil treatment on intermediate density lipoprotein, and subclasses of low density lipoprotein and high density lipoprotein in patients with combined hyperlipidemia.
Superko HR; Garrett BC; King SB; Momary KM; Chronos NA; Wood PD
Am J Cardiol; 2009 Feb; 103(3):387-92. PubMed ID: 19166694
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness and tolerability of simvastatin plus fenofibrate for combined hyperlipidemia (the SAFARI trial).
Grundy SM; Vega GL; Yuan Z; Battisti WP; Brady WE; Palmisano J
Am J Cardiol; 2005 Feb; 95(4):462-8. PubMed ID: 15695129
[TBL] [Abstract][Full Text] [Related]
6. Increased plasma levels of oxysterols, in vivo markers of oxidative stress, in patients with familial combined hyperlipidemia: reduction during atorvastatin and fenofibrate therapy.
Arca M; Natoli S; Micheletta F; Riggi S; Di Angelantonio E; Montali A; Antonini TM; Antonini R; Diczfalusy U; Iuliano L
Free Radic Biol Med; 2007 Mar; 42(5):698-705. PubMed ID: 17291993
[TBL] [Abstract][Full Text] [Related]
7. The level and species of plasma non-esterified fatty acids are not related to elevated plasma apolipoprotein B levels in familial combined hyperlipidemia.
Shamir R; Williams KJ; Cortner JL; Hudgins LC; Levine LC; McGee-Harper M; Fisher EA
J Med; 2001; 32(5-6):349-63. PubMed ID: 11958280
[TBL] [Abstract][Full Text] [Related]
8. [Biochemical diagnosis of hereditary hyperlipoproteinemias].
Tvorogova MG; Rozhkova TA; Alidzhanova KhG; Semenova OA; Sobolev AV; Kukharchuk VV; Titov VN
Ter Arkh; 1998; 70(4):9-15. PubMed ID: 9612894
[TBL] [Abstract][Full Text] [Related]
9. [Clinical and biochemical features of atherosclerosis main risk factors in children of probands with primary hyperlipidemia].
Alidzhanova KhG; Tvorogova MG; Rozhkova TA; Balakhonova TV; Vorob'eva LP; Masenko VP; Kukharchuk VV
Ter Arkh; 1998; 70(1):19-23. PubMed ID: 9532645
[TBL] [Abstract][Full Text] [Related]
10. Familial combined hyperlipidemia: upstream transcription factor 1 and beyond.
Lee JC; Lusis AJ; Pajukanta P
Curr Opin Lipidol; 2006 Apr; 17(2):101-9. PubMed ID: 16531745
[TBL] [Abstract][Full Text] [Related]
11. [Familial combined hyperlipidemia; solution on the horizon?].
Porkka K; Taskinen MR
Duodecim; 1995; 111(18):1755-62. PubMed ID: 9340268
[No Abstract] [Full Text] [Related]
12. [Lipid composition of high density lipoproteins in familial hyperlipoproteinemias].
Tvorogova MG; Vasin PN; Rozhkova TA; Kukharchuk VV; Titov VN
Vopr Med Khim; 1998; 44(5):452-8. PubMed ID: 9916260
[TBL] [Abstract][Full Text] [Related]
13. Evidence that non-lipid cardiovascular risk factors are associated with high prevalence of coronary artery disease in patients with heterozygous familial hypercholesterolemia or familial combined hyperlipidemia.
Skoumas I; Masoura C; Pitsavos C; Tousoulis D; Papadimitriou L; Aznaouridis K; Chrysohoou C; Giotsas N; Toutouza M; Tentolouris C; Antoniades C; Stefanadis C
Int J Cardiol; 2007 Oct; 121(2):178-83. PubMed ID: 17188767
[TBL] [Abstract][Full Text] [Related]
14. [Antioxidant vitamins status in patients with combined hyperlipidemia].
Pachocka LM; Bułhak-Jachymczyk B; Kłosiewicz-Latoszek L; Stolarska I; Grzybek A; Targosz U
Ann Acad Med Stetin; 2005; 51 Suppl 1():119-23. PubMed ID: 16602438
[TBL] [Abstract][Full Text] [Related]
15. Treatment of type IIb familial combined hyperlipidemia with the combination pravastatin-piperazine sultosilate.
Masana L; Villoria J; Sust M; Ros E; Plana N; Pérez-Jiménez F; Franco M; Oliván JJ; Pintó X; Videla S
Eur J Pharmacol; 2004 Aug; 496(1-3):205-12. PubMed ID: 15288592
[TBL] [Abstract][Full Text] [Related]
16. Subclasses of low-density lipoprotein and very low-density lipoprotein in familial combined hyperlipidemia: relationship to multiple lipoprotein phenotype.
Georgieva AM; van Greevenbroek MM; Krauss RM; Brouwers MC; Vermeulen VM; Robertus-Teunissen MG; van der Kallen CJ; de Bruin TW
Arterioscler Thromb Vasc Biol; 2004 Apr; 24(4):744-9. PubMed ID: 14751815
[TBL] [Abstract][Full Text] [Related]
17. Small, dense LDL and elevated apolipoprotein B are the common characteristics for the three major lipid phenotypes of familial combined hyperlipidemia.
Ayyobi AF; McGladdery SH; McNeely MJ; Austin MA; Motulsky AG; Brunzell JD
Arterioscler Thromb Vasc Biol; 2003 Jul; 23(7):1289-94. PubMed ID: 12750118
[TBL] [Abstract][Full Text] [Related]
18. [Endothelial dysfunction in a family with familial combined hyperlipidemia].
Karásek D; Vaverková H; Hutyra M; Halenka M; Novotnyý D; Budíková M; Slavík L
Vnitr Lek; 2003 Aug; 49(8):623-9. PubMed ID: 14518086
[TBL] [Abstract][Full Text] [Related]
19. Relationship between familial combined hyperlipidemia and insulin resistance.
Jackuliaková D; Vaverková H; Karásek D
Vnitr Lek; 2008 Nov; 54(11):1045-53. PubMed ID: 19069677
[TBL] [Abstract][Full Text] [Related]
20. Genetics of familial combined hyperlipidemia.
Naukkarinen J; Ehnholm C; Peltonen L
Curr Opin Lipidol; 2006 Jun; 17(3):285-90. PubMed ID: 16680034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
